Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP627519.RADpyhagb40Ew8ILUEK2iEDAYxBhgBitvuCX4rG0Y7YPk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP627519.RADpyhagb40Ew8ILUEK2iEDAYxBhgBitvuCX4rG0Y7YPk130_assertion type Assertion NP627519.RADpyhagb40Ew8ILUEK2iEDAYxBhgBitvuCX4rG0Y7YPk130_head.
- NP627519.RADpyhagb40Ew8ILUEK2iEDAYxBhgBitvuCX4rG0Y7YPk130_assertion wasGeneratedBy ECO_0000203 NP627519.RADpyhagb40Ew8ILUEK2iEDAYxBhgBitvuCX4rG0Y7YPk130_provenance.
- NP627519.RADpyhagb40Ew8ILUEK2iEDAYxBhgBitvuCX4rG0Y7YPk130_assertion wasDerivedFrom befree-20150227 NP627519.RADpyhagb40Ew8ILUEK2iEDAYxBhgBitvuCX4rG0Y7YPk130_provenance.
- NP627519.RADpyhagb40Ew8ILUEK2iEDAYxBhgBitvuCX4rG0Y7YPk130_assertion SIO_000772 16458133 NP627519.RADpyhagb40Ew8ILUEK2iEDAYxBhgBitvuCX4rG0Y7YPk130_provenance.
- NP627519.RADpyhagb40Ew8ILUEK2iEDAYxBhgBitvuCX4rG0Y7YPk130_assertion evidence source_evidence_literature NP627519.RADpyhagb40Ew8ILUEK2iEDAYxBhgBitvuCX4rG0Y7YPk130_provenance.
- NP627519.RADpyhagb40Ew8ILUEK2iEDAYxBhgBitvuCX4rG0Y7YPk130_assertion description "[We studied the modifier effect of platelet antigen polymorphism (PlA2) on platelet inhibition by acetylsalicylic acid (ASA, i.e., aspirin), clopidogrel, or their combination in patients with coronary heart disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627519.RADpyhagb40Ew8ILUEK2iEDAYxBhgBitvuCX4rG0Y7YPk130_provenance.